SCHEMBL13692913

SCHEMBL13692913

O=C1Nc2ccc(I)cc2CO1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.51
CYP11B2 P19099 2/20 0.51
TDP2 O95551 2/20 0.41
TGM2 P21980 1/20 0.41
CES1 P23141 1/20 0.41
PDE3B Q13370 2/20 0.38
PDE3A Q14432 2/20 0.38
KCNH2 Q12809 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
LRRK2 Q5S007 1/20 0.35
CTSC P53634 1/20 0.35
SYK P43405 2/20 0.33
ADRA2A P08913 1/20 0.33
PNMT P11086 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15788033 0.86 CYP11B1 (0.41) CYP11B1CYP11B2TDP2TGM2CES1
SCHEMBL10916724 0.79 CYP11B1 (0.51) CYP11B1CYP11B2PDE3BPDE3AKCNH2
SCHEMBL787497 0.79 CYP11B1 (0.51) CYP11B1CYP11B2TDP2TGM2CES1
SCHEMBL30695802 0.79 CYP11B1 (0.51) CYP11B1CYP11B2TDP2TGM2CES1
SCHEMBL3068531 0.79 AHR (0.56) CYP11B1CYP11B2TGM2CES1PDE3B
SCHEMBL434348 0.79 CYP11B1 (0.51) CYP11B1CYP11B2PDE3BPDE3AKCNH2
SCHEMBL3597262 0.79 CYP11B1 (0.51) CYP11B1CYP11B2PDE3BPDE3AKCNH2
SCHEMBL31261247 0.79 CYP11B1 (0.51) CYP11B1CYP11B2PDE3BPDE3AKCNH2
SCHEMBL21377526 0.79 TDP2 (0.34) CYP11B1CYP11B2TDP2TGM2CES1
SCHEMBL3597266 0.79 LMNA (0.51) CYP11B1CYP11B2PDE3BPDE3AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288945-B1 IMIDAZOPYRAZINES AND PYRAZOLOPYRIMIDINES AND THEIR USE AS AMPA RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-09-18 EP disclosed
WO-2009106577-A1 IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE NOVARTIS AG (CH) 2009-09-03 WO disclosed